Trial Profile
AFTER trial
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 03 Jul 2014
Price :
$35
*
At a glance
- Drugs Fulvestrant (Primary) ; Aromatase inhibitors
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms AFTER
- 03 Jul 2014 New trial record